Liz Bogaert

发表

CD123 Directed IgM Antibody-based T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release

B. Keyt, M. Kotturi, P. Hinton, 2022, Blood.

Complex PK-PD of an engineered IL-15/IL-15Rα-Fc fusion protein in cynomolgus monkeys: QSP modeling of lymphocyte dynamics.

J. Desjarlais, S. Ramanujan, R. Varma, 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure

J. Desjarlais, Suzanne Schubbert, R. Varma, 2018, Clinical Research (Excluding Clinical Trials).

Abstract 2784: Simultaneous checkpoint-checkpoint or checkpoint-costimulatory receptor targeting with bispecific antibodies promotes enhanced human T cell activation

J. Desjarlais, Alex Nisthal, R. Varma, 2018, Immunology.

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy

J. Desjarlais, Suzanne Schubbert, K. Avery, 2024, Frontiers in Pharmacology.